Drug factory · FDA FEI 3005910213
MW Encap Limited
Units 1-8 Oakbank Park Way, Livingston, United Kingdom
Problems found, fixed voluntarily at FDA's last inspection, Jun 24, 2021.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
5 drug inspections on record since 2010: 1 with no problems, 4 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Octreotide | Makes it and tests it | Amryt Pharmaceuticals Designated Activity Company, Chiesi USA, Inc. | 69880-120, 10122-550 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jun 24, 2021 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Feb 9, 2018 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jan 22, 2016 | No problems found | Drug Quality Assurance | — |
| Nov 20, 2014 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Sep 17, 2010 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; manufacture.